Seeking Alpha

Simcere Pharmaceutical Group (SCR)

()

News & PR
Market Currents

Buzz
Twitter: SCR

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Simcere Shuts Down Production in Rabies Vaccine Subsidiary over Quality Control

Dec 3 • ChinaBio Today • 1 Comment
AOB's Cash Generation Provides Backstop to Earnings Miss

Nov 17 • Jeffrey Walkenhorst • 3 Comments
Simcere Acquires Statin Manufacturing License

Nov 10 • ChinaBio Today • Comment!
The Complete List of Chinese ADR Stocks

Nov 4 • David Hunkar • 6 Comments
China Biotech Week in Review: Is CRO Consolidation a New Theme?

Nov 1 • ChinaBio Today • 1 Comment
Simcere Gains Majority Control of Vaccine Subsidiary

Oct 30 • ChinaBio Today • 1 Comment
China Biotech Week in Review: International Initiatives

Oct 25 • ChinaBio Today • Comment!
Simcere to Develop OSI Pharmaceutical Cancer Drug in China

Oct 21 • ChinaBio Today • 1 Comment
China Biotech Week in Review: 3 Life Science IPOs Coming Up

Sep 27 • ChinaBio Today • Comment!
China Starts Flu Vaccine Stockpile with Sinovac Order

Sep 6 • ChinaBio Today • Comment!
China Biotech Takes an Important Step: FDA Approved Clinical Trials

Aug 30 • ChinaBio Today • Comment!
Simcere Teams Up with Cancer Center to Develop Drugs

Aug 25 • ChinaBio Today • Comment!
American Oriental: Established Pharma with Large, Steady Free Cash Flow

Jul 14 • Jeffrey Walkenhorst • 3 Comments
Emerging Market Biotechs: Multiple Under-Appreciated Stocks

Jun 16 • Joe Kunkle • 2 Comments
China Rising: CCG's May 18th Chinese Investment Conference

Jun 12 • Barbara Horne • 1 Comment
China Biotech in Review: Deals, Approvals and More

May 31 • ChinaBio Today • Comment!
Simcere Pharma Follows Diversified Expansion Strategy

May 27 • ChinaBio Today • Comment!
China Biotech in Review: Deals and Earnings

May 24 • ChinaBio Today • 1 Comment
Simcere's Q1 Disappoints Investors

May 20 • ChinaBio Today • Comment!
Invention and Design Evident in China Biopharma

May 10 • ChinaBio Today • Comment!
Simcere Pharma Set to Produce Flu Drug in China

May 6 • ChinaBio Today • 1 Comment
China Biotech in Review: Cross Border Collaborations

Mar 16 • ChinaBio Today • 1 Comment
Simcere's Q4: Revenues Up, Earnings Down

Mar 13 • ChinaBio Today • Comment!
China Biopharma Continues to Expand Offerings

Jan 18 • ChinaBio Today • Comment!
Simcere Issues Net Income Warning for 2008

Jan 13 • ChinaBio Today • Comment!
China Bio in Review: More Fallout from Economic Crisis

Nov 9, 2008 • ChinaBio Today • Comment!
Investors Liked What They Saw in Simcere's Q3 Report

Nov 6, 2008 • ChinaBio Today • Comment!
China Bio Week-in-Review: Trials and Deals

Sep 7, 2008 • ChinaBio Today • Comment!
Simcere Shows Positive Data from Cancer Drug Trial

Sep 4, 2008 • ChinaBio Today • Comment!
Six Key Chinese Healthcare ADRs

Aug 8, 2008 • Michael McDonough • Comment!
China ADRs: Mixed July

Aug 6, 2008 • The Sun • 3 Comments
Simcere’s Q2 Fails Expectations

Aug 6, 2008 • ChinaBio Today • Comment!
Global Investing, BRIC by BRIC: Part II

Aug 5, 2008 • Martin Hutchinson • 6 Comments
China ADRs: Severe Loss in June

Jul 3, 2008 • The Sun • 11 Comments
China Biopharma Growth Metrics

May 19, 2008 • ChinaBio Today • Comment!
Simcere Granted SFDA Approval for Generic Antibiotic

May 15, 2008 • ChinaBio Today • 1 Comment
China Biopharma: What’s Not to Like?

May 11, 2008 • ChinaBio Today • 3 Comments
Simcere’s Q1: Revenue Increases 26%

May 7, 2008 • ChinaBio Today • Comment!
Biotech in Review: Investments in China Drug Development

Apr 28, 2008 • ChinaBio Today • Comment!
Simcere Buys Cancer Drug Company

Apr 23, 2008 • ChinaBio Today • Comment!
Simcere Books Solid 2007

Mar 5, 2008 • ChinaBio Today • Comment!

Simcere Pharmaceutical Group (SCR)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers